- R&D
FDA and CDC exploring unlikely relation between COVID-19 vaccine and stroke
The FDA and CDC have brought out new revelations that the revised COVID-19 injection from Pfizer Inc and its partner BioNTech could...Delivering mRNA Into Extracellular Vesicles Decreases Wrinkles in Mice, Study Finds
Extracellular vesicles (EVs) have been found to be a viable alternative to lipid nanoparticles for the delivery of mRNA to mice's skin,...Spiral Therapeutics completes $8.25M financing for phase 2 trial of hearing medication
Spiral Therapeutics has recently closed an $8.25 million financing round for the phase 2 research and development of SPT-2101, which is the...Pfizer Steps Back From Early-Stage Rare Disease R&D
Pfizer is withdrawing from research and development for rare diseases in their initial phases. As part of a rethinking of its strategy...
- Clinical
Serious adverse events result in Magenta stopping leukemia trial’s high-dose group
A serious adverse event occurred in the phase 1/2 trial of Magenta Therapeutics’ leukemia medicine which resulted in the company having to...FDA Pushes Back Lynparza Decision to March
The U.S. Food and Drug Administration (FDA) has postponed making a decision on Lynparza for metastatic castration-resistant prostate cancer (mCRPC), which is...FDA partial hold stands as Avidity shows evidence of the first targeting RNA into muscle
Avidity Biosciences has hinted that the latest phase 1/2 data of the first targeted delivery of RNA into muscle has been successful....Cytokinetics Set to Make Its Case For Omecamtiv Mecarbil to FDA
Cytokinetics is set to present the benefits of omecamtiv mecarbil - its heart failure drug - to the FDA's advisory committee. However,...
- Manufacturing
AstraZeneca teams up with G42 Healthcare to increase drug production in Abu Dhabi
AstraZeneca has signed a strategic partnership agreement with G42 Healthcare to manufacture medicinal therapies in Abu Dhabi. The agreement concentrates on teamwork...Breyanzi’s case strengthened by Bristol Myers amidst the confrontation with Gilead
A year ago when Breyanzi’s second-line LBCL (large B-cell lymphoma) key data was revealed by Bristol Myers Squibb which found that a...Biopharma newcomer Resilience buys AstraZeneca’s Ohio facility
AstraZeneca’s Ohio facility, which was part of the United States covid vaccine production network, has new ownership. The sale...Novo Nordisk expands facility to increase production
Novo Nordisk will invest $744 million to expand its clinical production facilities in a Copenhagen suburb. Novo Nordisk is...
- Commercial
Disappointing sales prompt AstraZeneca to pull out leukemia drug Lumoxiti from U.S. market
In a letter shared with healthcare providers, AstraZeneca has announced that it will be pulling its leukemia antibody-drug conjugate Lumoxiti (moxetumomab pasudotox-tdfk)...Sanofi’s Venture Capital units to receive over $750 million in investment to boost firm’s investment capabilities
After a successful last year in which Sanofi Ventures made its second-highest number of deals, 10 rounds of backing that amount to...Spiral Therapeutics completes $8.25M financing for phase 2 trial of hearing medication
Spiral Therapeutics has recently closed an $8.25 million financing round for the phase 2 research and development of SPT-2101, which is the...Alphabet’s health subsidiary Verily cuts staff by 15% in a bid to strategize and reorganize
In an email shared with Verily employees recently, the company CEO Stephen Gillett announced that they will be laying off 15% of...
- Technology
Canon Healthcare announces new subsidiary in a bid to expand presence in the U.S.
Japanese tech giant Canon has announced the opening of its second med tech-focused subsidiary in the U.S., with the first being Canon...Agreement for the commercialization of mammography AI reached between iCAD and Google Health
A deal was penned between medical tech company iCAD and Google Health to use Google’s AI technology in iCAD’s breast imaging solutions....Ionis And Metagenomi Team Up For Ambitious Genetic Targeting Pact
Ionis Pharmaceuticals and startup gene editing firm Metagenomi have just signed a multi-target research deal that has the potential to generate nearly...BioMed X and Sanofi join hands to use AI for drug development
The failure of new drug therapy candidates in the clinical development process has plagued the pharmaceutical industry for some time now. The...
- Regulatory
Roche’s Xofluza approved by European Commission for children’s influenza treatment
The EC (European Commission) has approved Roche’s influenza treatment called Xofluxa, targeted toward children aged over a year. It can be used...AstraZeneca receives FDA approval for its Asthma drug AirSupra
AstraZeneca has successfully received approval for its Asthma therapy- AirSupra. AstraZeneca (AZ) representative stated that the FDA has authorised...Spectrum Labs Recalls Three Batches of Epinephrine Following Discoloration Complains
Spectrum Laboratory Products has voluntarily recalled all batches of epinephrine USP, a bulk API powder utilized in the production of the pharmaceutical...FDA accelerated approval decision on Alzheimer’s drug likely to come soon
According to Biogen and Eisai, the accelerated approval decision for their Alzheimer’s drug could be made in early January by the FDA.
- Insights
Patient Engagement – What History Teaches Us About Pharma’s Future Evolution
The pharmaceutical industry continues to grow by leaps and bounds. Advancements are happening on a weekly basis. But every time we take...Monoclonal Antibodies Offer Much Needed Protection for the Immunocompromised Population
Even though we don’t feel it or notice it, each minute, our bodies’ immune systems are hard at work eliminating abnormal cells,...OMNICHANNEL ORCHESTRATION IS MORE THAN JUST THE NEXT BEST ACTIONS
Omnichannel orchestration is critical to delivering a customized and relevant experience to each customer. If designed and executed correctly, responsive omnichannel marketing...The Evolution of Treatment: Use of Anticoagulation in Cancer Patients
Cancer patients face many heightened health risks after their initial diagnosis. While the disease itself is a leading cause of death worldwide,...
- More
- Podcast
- R&D
FDA and CDC exploring unlikely relation between COVID-19 vaccine and stroke
The FDA and CDC have brought out new revelations that the revised COVID-19 injection from Pfizer Inc and its partner BioNTech could...Delivering mRNA Into Extracellular Vesicles Decreases Wrinkles in Mice, Study Finds
Extracellular vesicles (EVs) have been found to be a viable alternative to lipid nanoparticles for the delivery of mRNA to mice's skin,...Spiral Therapeutics completes $8.25M financing for phase 2 trial of hearing medication
Spiral Therapeutics has recently closed an $8.25 million financing round for the phase 2 research and development of SPT-2101, which is the...Pfizer Steps Back From Early-Stage Rare Disease R&D
Pfizer is withdrawing from research and development for rare diseases in their initial phases. As part of a rethinking of its strategy...
- Clinical
Serious adverse events result in Magenta stopping leukemia trial’s high-dose group
A serious adverse event occurred in the phase 1/2 trial of Magenta Therapeutics’ leukemia medicine which resulted in the company having to...FDA Pushes Back Lynparza Decision to March
The U.S. Food and Drug Administration (FDA) has postponed making a decision on Lynparza for metastatic castration-resistant prostate cancer (mCRPC), which is...FDA partial hold stands as Avidity shows evidence of the first targeting RNA into muscle
Avidity Biosciences has hinted that the latest phase 1/2 data of the first targeted delivery of RNA into muscle has been successful....Cytokinetics Set to Make Its Case For Omecamtiv Mecarbil to FDA
Cytokinetics is set to present the benefits of omecamtiv mecarbil - its heart failure drug - to the FDA's advisory committee. However,...
- Manufacturing
AstraZeneca teams up with G42 Healthcare to increase drug production in Abu Dhabi
AstraZeneca has signed a strategic partnership agreement with G42 Healthcare to manufacture medicinal therapies in Abu Dhabi. The agreement concentrates on teamwork...Breyanzi’s case strengthened by Bristol Myers amidst the confrontation with Gilead
A year ago when Breyanzi’s second-line LBCL (large B-cell lymphoma) key data was revealed by Bristol Myers Squibb which found that a...Biopharma newcomer Resilience buys AstraZeneca’s Ohio facility
AstraZeneca’s Ohio facility, which was part of the United States covid vaccine production network, has new ownership. The sale...Novo Nordisk expands facility to increase production
Novo Nordisk will invest $744 million to expand its clinical production facilities in a Copenhagen suburb. Novo Nordisk is...
- Commercial
Disappointing sales prompt AstraZeneca to pull out leukemia drug Lumoxiti from U.S. market
In a letter shared with healthcare providers, AstraZeneca has announced that it will be pulling its leukemia antibody-drug conjugate Lumoxiti (moxetumomab pasudotox-tdfk)...Sanofi’s Venture Capital units to receive over $750 million in investment to boost firm’s investment capabilities
After a successful last year in which Sanofi Ventures made its second-highest number of deals, 10 rounds of backing that amount to...Spiral Therapeutics completes $8.25M financing for phase 2 trial of hearing medication
Spiral Therapeutics has recently closed an $8.25 million financing round for the phase 2 research and development of SPT-2101, which is the...Alphabet’s health subsidiary Verily cuts staff by 15% in a bid to strategize and reorganize
In an email shared with Verily employees recently, the company CEO Stephen Gillett announced that they will be laying off 15% of...
- Technology
Canon Healthcare announces new subsidiary in a bid to expand presence in the U.S.
Japanese tech giant Canon has announced the opening of its second med tech-focused subsidiary in the U.S., with the first being Canon...Agreement for the commercialization of mammography AI reached between iCAD and Google Health
A deal was penned between medical tech company iCAD and Google Health to use Google’s AI technology in iCAD’s breast imaging solutions....Ionis And Metagenomi Team Up For Ambitious Genetic Targeting Pact
Ionis Pharmaceuticals and startup gene editing firm Metagenomi have just signed a multi-target research deal that has the potential to generate nearly...BioMed X and Sanofi join hands to use AI for drug development
The failure of new drug therapy candidates in the clinical development process has plagued the pharmaceutical industry for some time now. The...
- Regulatory
Roche’s Xofluza approved by European Commission for children’s influenza treatment
The EC (European Commission) has approved Roche’s influenza treatment called Xofluxa, targeted toward children aged over a year. It can be used...AstraZeneca receives FDA approval for its Asthma drug AirSupra
AstraZeneca has successfully received approval for its Asthma therapy- AirSupra. AstraZeneca (AZ) representative stated that the FDA has authorised...Spectrum Labs Recalls Three Batches of Epinephrine Following Discoloration Complains
Spectrum Laboratory Products has voluntarily recalled all batches of epinephrine USP, a bulk API powder utilized in the production of the pharmaceutical...FDA accelerated approval decision on Alzheimer’s drug likely to come soon
According to Biogen and Eisai, the accelerated approval decision for their Alzheimer’s drug could be made in early January by the FDA.
- Insights
Patient Engagement – What History Teaches Us About Pharma’s Future Evolution
The pharmaceutical industry continues to grow by leaps and bounds. Advancements are happening on a weekly basis. But every time we take...Monoclonal Antibodies Offer Much Needed Protection for the Immunocompromised Population
Even though we don’t feel it or notice it, each minute, our bodies’ immune systems are hard at work eliminating abnormal cells,...OMNICHANNEL ORCHESTRATION IS MORE THAN JUST THE NEXT BEST ACTIONS
Omnichannel orchestration is critical to delivering a customized and relevant experience to each customer. If designed and executed correctly, responsive omnichannel marketing...The Evolution of Treatment: Use of Anticoagulation in Cancer Patients
Cancer patients face many heightened health risks after their initial diagnosis. While the disease itself is a leading cause of death worldwide,...
- More
- Podcast
Editor Picks
Life Science Voice Top Five Newsletter January 2023
This week we see that abortion rights continue to be a hot...
Epigenetic Treatment Stimulates Spinal Cord Regeneration in Mice
A research group led by scientists from Imperial College London has found...
Oncopeptides’ Pepaxto to Remain Sidelined From the U.S. Market
Pepaxto, the multiple myeloma treatment drug from the biotech company Oncopeptides, will...
Must Read
FDA and CDC exploring unlikely relation between COVID-19 vaccine and stroke
The FDA and CDC have brought out new revelations that the revised...
Disappointing sales prompt AstraZeneca to pull out leukemia drug Lumoxiti from U.S. market
In a letter shared with healthcare providers, AstraZeneca has announced that it...
Sanofi’s Venture Capital units to receive over $750 million in investment to boost firm’s investment capabilities
After a successful last year in which Sanofi Ventures made its second-highest...
About Us
Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.
Contact us: reachout(at)lifescivoice.com